Claro Scientific today announced that the Company is scheduled to present at the SEMDA 2012 Conference  in Atlanta, GA this week.

Press release here

Claro Scientific wins first place in the early stage shoot out competition at SEBIO.  Press release here.

Claro Scientific today announced that the Company is scheduled to present at the Southeast BIO Investor Forum and ibiliti’s medtech 11 conference in Chapel Hill, NC this week.  Press release here.

“Claro Scientific is testing blood by using beams of light rather than chemicals.”  See the Florida Trend article here.

Claro Scientific has been selected to present at AdvaMed 2011, September 26-28, 2011.  AdvaMed, The MedTech Conference is the premier medical technology conference for CEOs, business executives, policy makers, financiers, media, and industry stakeholds from around the world.  Press release here.

Dr. Luis Garcia-Rubio, Claro’s Chief Scientific Officer, presents results from SpectraWave Protein Solutions at the 25th Anniversary of the Protein Society.  These results focus on protein folding and aggregate (oligomeric) distributions.  Claro press release HERE.

World Malaria Day was established by the World Health Organization in May 2007 and is held on April 25th each year. Events are held around the world to recognize efforts to control malaria and make progress towards a goal of no malaria deaths by 2015. For 2011, the theme for World Malaria Day was “Achieving Progress and Impact.”

Although much progress has been made, 3.3 billion people in 106 countries are still at risk for being infected with malaria this year. In 2009, 781 000 people died from malaria, mainly women and children in Africa. Diagnosing malaria infections continues to present significant challenges for healthcare delivery. According to WHO’s World Malaria Report 2010, the percentage of cases tested was less than 20% in 21 countries in Africa. The study results also indicate that many patients are receiving treatment without confirmatory diagnosis. That will contribute to increasing rates of drug resistance.

In partnership with PATH, Claro is part of the progress in eliminating malaria deaths. We will have an impact by advancing a combined malaria and anemia rapid diagnostic test using our SpectraWave system. We are committed to implementing innovative technology to address critical health needs for underserved populations in the developing world.
In marking World Malaria Day 2011, Claro prepared a summary describing this program in more detail.

Be sure to follow the progress of our market and form factor research studies with PATH in Kenya in summer 2011 on our website.

 Claro Scientific announces Notice of Allowance from U.S. Patent and Trademark Office for Blood Culture. 

Claro press release HERE

Dr. Jennifer Smith, Claro’s Principal Scientist, will be presenting results from an on-going clinical study for the identification of bacterial pathogens.  Claro Press Release HERE

St. Petersburg, FL–(December 9, 2010) — Claro Scientific, LLC has been invited to present at OneMedForum in San Francisco 2011 on January 10-13, 2011 at Sir Francis Drake Hotel at 450 Powell Street, San Francisco, CA 94102.

According to OneMedPlace Science Editor and Writer Romulo Hurtado, Ph.D., “Spectroscopy is a staple scientific methodology for the analysis of biological and chemical compounds, utilized for such wide varying purposes as genetic content analysis and the identification of the elemental composition of a chemical. The advancement of this technique by Claro Scientific into a multi-dimensional platform has important and broad implications, with the potential to serve as a breakthrough tool in different scientific fields, for different purposes.”

The fourth annual OneMedForum event continues to be a vital connecting point for healthcare/life science-focused emerging companies, business development executives and investors. The three-day event will include industry-focused panel sessions, numerous networking opportunities, and more than 125 presentations by some of the most promising emerging medical device, biotech and health information companies.

OneMedForum San Francisco 2011, runs concurrently with the J.P Morgan conference that provides efficient access to the companies that shape the future of the rapidly changing healthcare landscape. “Our mission is one of discovery. And our goal is to find the most promising and least known opportunities among both public and private companies.  Our mission is to bring together investors, business development executives, and the brightest new ideas and emerging healthcare and life science companies. Our panel sessions provide Insights for investors to better understand and identify prospective investment opportunities among the 100+ emerging public and private companies that will present over the two and a half days” said Brett Johnson, CEO and OneMedPlace.

“We sought to get a variety of perspectives to give investors genuine insight as to where the opportunities lie,” said J. Casey McGlynn, chair of the programming committee. “Our goal is to provide the big picture and then present actual investment opportunities in a time efficient format such that investors can meet presenting companies throughout the conference and as well as after the event.”

The conference will feature presentations by over 100 of the most promising emerging public and private companies. A Health Technology session will occur on Thursday morning and a China Forum educational seminar will be held Monday, January 10th, before the conference starts. Numerous workshops will also occur throughout the conference.

Event:  OneMedForum 2011

When: January 11-13, 2011 at 11:40 a.m. (EDT)

Place: Sir Francis Drake Hotel, 450 Powell Street, Union Square, San Francisco, CA

Pre-registration is required: http://www.onemedplace.com/forum/

To meet with Claro at this event, please contact Thomas McLain at thomas.mclain@clarosci.com.

About OneMedForum

Founded in 2008, OneMedForum events are held biannually in San Francisco in January and in New York in June. They are designed to create a communications platform for emerging companies to connect with strategic partners and investors.

About Claro Scientific, LLC

Claro Scientific is developing innovative diagnostic systems using its patented multidimensional optical profiling technology.  Claro’s systems deliver highly precise, detailed and quantitative information about the composition and character of biologic and non-biologic samples in minutes.  These products have significant competitive advantages in several commercial markets including protein and cellular characterization, biotechnology process analysis and research, medical diagnostics, personalized health monitoring, blood banking, biodefense, environmental monitoring, agriculture, food safety and veterinary medicine.  Each application of the technology is developed from the same core design.

For further information, please visit: www.clarosci.com

# # #